STAT

With brain trauma, surgeons don’t always know if an operation will help. Could AI change that?

Can AI be relied on to guide treatment of TBI patients, when the consequences of a wrong decision are so catastrophic?
Researchers are developing AI systems that would use CT scans and other data to guide treatment of patients with traumatic brain injuries.

A paramedic gurney flies through the trauma bay carrying an unconscious elderly gentleman. He is already intubated and has a hive of doctors and nurses running alongside, placing intravenous lines and injecting medicine into his blood stream. He’s suffered a serious head injury in a car accident. With every passing minute, blood accumulates in the space above his brain, pressing on vital structures.

It was a cold winter afternoon in 2017, and the patient had been taken to a major regional hospital. When he arrived, the neurosurgeon on call had minutes to counsel the family on the man’s prognosis, and together they needed to decide whether to operate; surgery could save the patient’s life, but it could also commit him to a life dependent on a ventilator and a feeding tube, trapped in a coma or with limited brain function. Sometimes the quality of life matters more

You’re reading a preview, subscribe to read more.

More from STAT

STAT1 min read
STAT+: Senate Drug Shortage Bill Would Pay Hospitals Bonuses For Good Contracting Practices
A bipartisan Senate bill takes a new approach to persistent drug shortages: have Medicare pay bonuses to hospitals and physicians for contracting that ensures a steady supply.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About GLP-1 Spending, Biosimilar Patient Costs, And More
Spending on GLP-1 drugs like Ozempic and Wegovy ballooned last year and they're set to cost the U.S. health care system and the federal government still more.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About FTC Fighting ‘Junk’ Patents, Pfizer Direct-to-consumer Plans, And More
The FTC expanded its campaign against pharmaceutical companies for filing what it calls “junk” patent listings for 20 different brand-name treatments.

Related Books & Audiobooks